BIOMUNEX

BIOMUNEX is a biopharmaceutical company based in Paris (FR), with an affiliate in Cambridge, Massachusetts, USA (established in 2019), with a seasoned and international leadership team and board. Biomunex is discovering and developing differentiated immunotherapeutic approaches based on data driven biology, to address the unmet medical needs in oncology. BIOMUNEX focuses on inventing disruptive biological approaches and bringing breakthrough therapies to patients based on the discovery and development of next generation proprietary BiXAb® bi- and multi-specific antibodies... BIOMUNEX Pharmaceuticals is a French biopharmaceutical company, based in Paris (FR) and Cambridge (MA, USA), focused on the discovery and development of breakthrough immunotherapies using its unique and proprietary BiXAb® technology to create next generation bi- and multi-specific antibodies for oncology... We are committed to provide oncologists and patients with immunotherapies that are novel, efficacious and..

Also known as: BIOMUNEX Pharmaceuticals

Primary location: Paris France